Deutsche Bank
IDYA icon

Deutsche Bank’s IDEAYA Biosciences IDYA Stock Holding History

Deutsche Bank’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.5M Sell
93,844
-284,598
-75% -$8.71M ﹤0.01% 1563
2026
Q1 		$12.6M Buy
378,442
+9,961
+3% +$334K ﹤0.01% 985
2025
Q4 		$12.7M Sell
368,481
-37,164
-9% -$1.18M ﹤0.01% 1009
2025
Q3 		$11M Sell
405,645
-9,754
-2% -$236K ﹤0.01% 1022
2025
Q2 		$8.73M Sell
415,399
-52,062
-11% -$999K ﹤0.01% 1040
2025
Q1 		$7.66M Buy
467,461
+94,482
+25% +$2.01M ﹤0.01% 1094
2024
Q4 		$9.59M Buy
372,979
+24,205
+7% +$685K ﹤0.01% 1044
2024
Q3 		$11M Buy
348,774
+13,002
+4% +$493K ﹤0.01% 988
2024
Q2 		$11.8M Buy
335,772
+30,860
+10% +$1.22M 0.01% 959
2024
Q1 		$13.4M Buy
304,912
+210,544
+223% +$9.05M 0.01% 942
2023
Q4 		$3.36M Buy
94,368
+64,459
+216% +$1.92M ﹤0.01% 1427
2023
Q3 		$807K Buy
29,909
+4,054
+16% +$103K ﹤0.01% 1869
2023
Q2 		$608K Sell
25,855
-4,230
-14% -$87K ﹤0.01% 2251
2023
Q1 		$413K Buy
30,085
+10,996
+58% +$183K ﹤0.01% 2604
2022
Q4 		$347K Buy
19,089
+3,554
+23% +$59.8K ﹤0.01% 2652
2022
Q3 		$232K Sell
15,535
-2,381
-13% -$30.9K ﹤0.01% 2863
2022
Q2 		$247K Buy
17,916
+127
+0.7% +$1.41K ﹤0.01% 3053
2022
Q1 		$199K Sell
17,789
-2,118
-11% -$31.2K ﹤0.01% 3268
2021
Q4 		$471K Buy
19,907
+1,063
+6% +$24.7K ﹤0.01% 2890
2021
Q3 		$480K Buy
18,844
+2,181
+13% +$50.9K ﹤0.01% 3065
2021
Q2 		$350K Buy
16,663
+6,335
+61% +$130K ﹤0.01% 3455
2021
Q1 		$243K Sell
10,328
-987
-9% -$19.1K ﹤0.01% 3531
2020
Q4 		$158K Buy
11,315
+3,332
+42% +$45.1K ﹤0.01% 3598
2020
Q3 		$100K Buy
7,983
+2,447
+44% +$30.3K ﹤0.01% 3547
2020
Q2 		$79K Buy
+5,536
New +$43.6K ﹤0.01% 3571

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Deutsche Bank's IDYA Position: Q2 2026 in Review

Deutsche Bank reduced its IDEAYA Biosciences (IDYA) stake by 75% in Q2 2026, selling an estimated $8.71M and leaving 93,844 shares worth $3.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1563.

Deutsche Bank first reported a position in IDYA in Q2 2020 and has held it in 25 quarters since. The position peaked at $13.4M in Q1 2024. 285 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Deutsche Bank held 93,844 shares of IDEAYA Biosciences worth $3.5M as of Q2 2026.
  • Deutsche Bank sold 284,598 IDEAYA Biosciences shares in Q2 2026, an estimated $8.71M.
  • IDEAYA Biosciences made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #1563 holding.
  • Deutsche Bank first reported a position in IDEAYA Biosciences in Q2 2020 and has held it in 25 quarters since.
  • Deutsche Bank's IDEAYA Biosciences position peaked at $13.4M in Q1 2024.
  • 285 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.